Inventor · disambiguated record
Guangmei Yan
Also filed as: YAN GUANGMEI
14 granted patents·5 pending applications·10 citations·filing 2004–2023
86Inventor score
Files withGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD7GUANGZHOU CELLPROTEK PHARM CO LTD6YAN GUANGMEI5GUANGZHOU CELLPROTEK PHARMACEUTICAL LTD1
Top patents by PatentIndex Score
19 records- 0176US10835539B2Neuro-protective agents and uses thereofGUANGZHOU CELLPROTEK PHARM CO LTD·Filed 2019·Granted Nov 17, 2020·1 cites·6 claims
- 0275US11234968B2Use of VCP inhibitor and oncolytic virus in the preparation of an anti-tumor drugGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2017·Granted Feb 1, 2022·1 cites·12 claims
- 0373US12319750B2Hexokinase 2-specific inhibitors for use in acute central nervous system injuryGUANGZHOU CELLPROTEK PHARM CO LTD·Filed 2023·Granted Jun 3, 2025·0 cites·3 claims
- 0473US11584802B2Hexokinase 2-specific inhibitors for use in acute central nervous system injuryGUANGZHOU CELLPROTEK PHARM CO LTD·Filed 2018·Granted Feb 21, 2023·1 cites·3 claims
- 0573US8809309B2Use of 5α-androstane (alkyl)-3β,5,6β-triol in preparation of neuroprotective drugsYAN GUANGMEI·Filed 2011·Granted Aug 19, 2014·5 cites·4 claims
- 0668US10517909B2Use of alphavirus in preparation of antitumor drugsGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2015·Granted Dec 31, 2019·1 cites·45 claims
- 0765US9265837B15α-androstane-3β,5,6β-triol injection and preparation method thereforYAN GUANGMEI·Filed 2015·Granted Feb 23, 2016·1 cites·3 claims
- 0858US11235011B2Use of alphavirus in preparation of antitumor drugsGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2019·Granted Feb 1, 2022·0 cites·20 claims
- 0953US10980850B2Use of IAP inhibitor and oncolytic virus in preparation of anti-tumor drugGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2017·Granted Apr 20, 2021·0 cites·13 claims
- 1049US11911396B2Use of compound in preparation of drug for treating cerebral small vessel diseaseGUANGZHOU CELLPROTEK PHARM CO LTD·Filed 2018·Granted Feb 27, 2024·0 cites·14 claims
- 1149US11382921B2Use of compounds in preparation of a medicament for treatment of hemorrhagic strokeGUANGZHOU CELLPROTEK PHARM CO LTD·Filed 2018·Granted Jul 12, 2022·0 cites·18 claims
- 1247US9320743B2Use of 5α-androstane-3β,5,6β-triol in preparation of neuroprotective drugsGUANGZHOU CELLPROTEK PHARMACEUTICAL LTD·Filed 2014·Granted Apr 26, 2016·0 cites·9 claims
- 1346US2021228660A1Use of proteasome inhibitor and alphavirus in preparation of anti-tumor medicamentGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 1445US9161985B25α-androstane (alkyl)-3β, 5, 6β-triol injection and preparation method thereforYAN GUANGMEI·Filed 2011·Granted Oct 20, 2015·0 cites·7 claims
- 1543US2020405793A1Use of mevalonate metabolic pathway inhibitor and alphavirus in preparing anti-tumor drugGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 1641US2019183948A1Use of bcl-xl inhibitor and oncolytic virus in preparation of antitumor drugGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2017·Application pending·0 cites
- 1739US2008312170A1Fibrinolysin of Agkistrodon Acutus Venom and its UsageYAN GUANGMEI·Filed 2004·Application pending·0 cites
- 1839US2010152150A1The application of marine steroid in preparing the medicine of treating neurons damagingYAN GUANGMEI·Filed 2006·Application pending·0 cites
- 1931US10357500B2Neuro-protective agents and uses thereofGUANGZHOU CELLPROTEK PHARM CO LTD·Filed 2015·Granted Jul 23, 2019·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Guangmei Yan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →